We are pleased to announce that Dr Ulrike Gorochowski has joined Dimension’s founding team as Chief Operating Officer! Ulrike brings deep expertise in biotechnology, rapid assay development and evaluation, and project management to the team. Our CEO Dr Arne Scott: “Ulrike and I worked really closely together for 4-years at Rosa Biotech. She is an exceptional scientist and formidable operator, and I couldn’t be happier to have her building Dimension with me from the very beginning”.

Ulrike will initially lead the development of Dimension's rapid assay technology for glycocalyx evaluation. She’ll then be key to delivering these tools to end-users, building out the business, and delivering the company’s wider mission to make microvascular health and disease routinely detectable in the clinic and in clinical research.

Welcome on board Ulrike!